Suppr超能文献

从头设计蛋白质的计算方法及其在人类免疫缺陷病毒 1、嘌呤核苷磷酸化酶、泛素特异性蛋白酶 7 和组蛋白去甲基酶中的应用。

Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.

机构信息

Department of Chemical Engineering, Princeton University, Princeton, NJ 08544, USA.

出版信息

Curr Drug Targets. 2010 Mar;11(3):264-78. doi: 10.2174/138945010790711914.

Abstract

This paper provides an overview of computational de novo protein design methods, highlighting recent advances and successes. Four protein systems are described that are important targets for drug design: human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases. Target areas for drug design for each protein are described, along with known inhibitors, focusing on peptidic inhibitors, but also describing some small-molecule inhibitors. Computational design methods that have been employed in elucidating these inhibitors for each protein are outlined, along with steps that can be taken in order to apply computational protein design to a system that has mainly used experimental methods to date.

摘要

本文概述了计算从头设计蛋白质的方法,重点介绍了最近的进展和成功。描述了四个对药物设计很重要的蛋白质系统:人类免疫缺陷病毒 1、嘌呤核苷磷酸化酶、泛素特异性蛋白酶 7 和组蛋白去甲基酶。描述了每个蛋白质的药物设计目标区域,以及已知的抑制剂,重点介绍了肽类抑制剂,但也描述了一些小分子抑制剂。概述了为每个蛋白质阐明这些抑制剂所采用的计算设计方法,以及为一个迄今为止主要使用实验方法的系统应用计算蛋白质设计可以采取的步骤。

相似文献

2
Structural analyses reveal two distinct families of nucleoside phosphorylases.
Biochem J. 2002 Jan 1;361(Pt 1):1-25. doi: 10.1042/0264-6021:3610001.
3
Drugs by design.
Sci Am. 1993 Dec;269(6):92-8. doi: 10.1038/scientificamerican1293-92.
4
Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11540-4. doi: 10.1073/pnas.88.24.11540.
5
Application of X-ray crystallographic methods in the design of purine nucleoside phosphorylase inhibitors.
Ann N Y Acad Sci. 1993 Jun 23;685:237-47. doi: 10.1111/j.1749-6632.1993.tb35871.x.
6
Structure-based design of inhibitors of purine nucleoside phosphorylase. 5. 9-Deazahypoxanthines.
J Med Chem. 1994 Jul 22;37(15):2477-80. doi: 10.1021/jm00041a027.
9
Purine nucleoside phosphorylase: a target for drug design.
Med Res Rev. 1993 May;13(3):209-28. doi: 10.1002/med.2610130302.
10
Determining the structural basis for specificity of ligands using crystallographic screening.
Cell Biochem Biophys. 2006;44(3):405-11. doi: 10.1385/CBB:44:3:405.

引用本文的文献

1
Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides.
Virus Res. 2022 Jul 2;315:198769. doi: 10.1016/j.virusres.2022.198769. Epub 2022 Apr 14.
2
Bioprospecting of microbial enzymes: current trends in industry and healthcare.
Appl Microbiol Biotechnol. 2022 Mar;106(5-6):1813-1835. doi: 10.1007/s00253-022-11859-5. Epub 2022 Mar 7.
7
Free energies for coarse-grained proteins by integrating multibody statistical contact potentials with entropies from elastic network models.
J Struct Funct Genomics. 2011 Jul;12(2):137-47. doi: 10.1007/s10969-011-9113-3. Epub 2011 Jun 15.
8
Multibody coarse-grained potentials for native structure recognition and quality assessment of protein models.
Proteins. 2011 Jun;79(6):1923-9. doi: 10.1002/prot.23015. Epub 2011 Apr 19.

本文引用的文献

1
The dead-end elimination theorem and its use in protein side-chain positioning.
Nature. 1992 Apr 9;356(6369):539-42. doi: 10.1038/356539a0.
2
Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework.
Biophys J. 2010 Nov 17;99(10):3445-53. doi: 10.1016/j.bpj.2010.09.050.
3
New compstatin variants through two de novo protein design frameworks.
Biophys J. 2010 May 19;98(10):2337-46. doi: 10.1016/j.bpj.2010.01.057.
4
Predicting protein ligand binding sites by combining evolutionary sequence conservation and 3D structure.
PLoS Comput Biol. 2009 Dec;5(12):e1000585. doi: 10.1371/journal.pcbi.1000585. Epub 2009 Dec 4.
5
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.
Mol Cancer Ther. 2009 Aug;8(8):2286-95. doi: 10.1158/1535-7163.MCT-09-0097. Epub 2009 Aug 11.
6
Protein design by sampling an undirected graphical model of residue constraints.
IEEE/ACM Trans Comput Biol Bioinform. 2009 Jul-Sep;6(3):506-16. doi: 10.1109/TCBB.2008.124.
7
Backbone and sidechain 1H, 13C and 15N resonance assignments of the Bright/ARID domain from the human JARID1C (SMCX) protein.
Biomol NMR Assign. 2008 Jun;2(1):9-11. doi: 10.1007/s12104-007-9071-7. Epub 2007 Dec 8.
8
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.
Nature. 2009 Jun 11;459(7248):847-51. doi: 10.1038/nature08036.
10
Synthesis of analogs of forodesine HCl, a human purine nucleoside phosphorylase inhibitor-Part II.
Bioorg Med Chem Lett. 2009 May 15;19(10):2627-9. doi: 10.1016/j.bmcl.2009.04.018. Epub 2009 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验